Cargando…
Quality of life assessment among multiple sclerosis patients in Saudi Arabia
OBJECTIVES: To determine the quality of life (QoL) among multiple sclerosis (MS) patients in Kingdom of Saudi Arabia. METHODS: A cross-sectional study was carried out to assess the QoL of MS patients during the period from November 2016 to May 2017. Patients were recruited from tertiary hospitals in...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Riyadh : Armed Forces Hospital
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8015454/ https://www.ncbi.nlm.nih.gov/pubmed/29664456 http://dx.doi.org/10.17712/nsj.2018.2.20170335 |
_version_ | 1783673679167619072 |
---|---|
author | Alhazzani, Adel A. Alqahtani, Mohammed S. Alahmari, Mohammed S. Asiri, Muhannad A. Alamri, Noof M. Sarhan, Leen A. Alkhashrami, Shahad S. Asiri, Abdullmgeed A. |
author_facet | Alhazzani, Adel A. Alqahtani, Mohammed S. Alahmari, Mohammed S. Asiri, Muhannad A. Alamri, Noof M. Sarhan, Leen A. Alkhashrami, Shahad S. Asiri, Abdullmgeed A. |
author_sort | Alhazzani, Adel A. |
collection | PubMed |
description | OBJECTIVES: To determine the quality of life (QoL) among multiple sclerosis (MS) patients in Kingdom of Saudi Arabia. METHODS: A cross-sectional study was carried out to assess the QoL of MS patients during the period from November 2016 to May 2017. Patients were recruited from tertiary hospitals in 5 regions in the kingdom. Clinical and demographic data were collected and information on patients’ health status using the self-report SF-36 questionnaire to assess QoL. The Patient Determined Disease Steps (PDDS) was used to measure disability. Data were analyzed using descriptive statistics, the Mann–Whitney test, the Kruskal Wallis test and Spearman’s coefficient correlation. RESULTS: From the 598 MS patients studied, 384 (64.2%) were female. The mean score for males was higher than females in all SF-36 QoL subscales. The mean age was 32.4 years (SD=8.4). The mean duration of illness was 6.5 years. Patients had the lowest scores in role motioning/emotional scale (mean=42.6, SD=43.3). The PDDS was negatively correlated with all SF-36 QoL subscales. Self Report-36 QoL for MS patients differed significantly through demographic characteristics at a level of significance of 0.05. CONCLUSIONS: Multiple Sclerosis patients have a low QoL score and need more comprehensive management by their treating physicians. Further development of the registration will provide access to the entire population of MS patients and help comprehensively analyze the factors that affect the quality of their lives. |
format | Online Article Text |
id | pubmed-8015454 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Riyadh : Armed Forces Hospital |
record_format | MEDLINE/PubMed |
spelling | pubmed-80154542021-08-13 Quality of life assessment among multiple sclerosis patients in Saudi Arabia Alhazzani, Adel A. Alqahtani, Mohammed S. Alahmari, Mohammed S. Asiri, Muhannad A. Alamri, Noof M. Sarhan, Leen A. Alkhashrami, Shahad S. Asiri, Abdullmgeed A. Neurosciences (Riyadh) Original Article OBJECTIVES: To determine the quality of life (QoL) among multiple sclerosis (MS) patients in Kingdom of Saudi Arabia. METHODS: A cross-sectional study was carried out to assess the QoL of MS patients during the period from November 2016 to May 2017. Patients were recruited from tertiary hospitals in 5 regions in the kingdom. Clinical and demographic data were collected and information on patients’ health status using the self-report SF-36 questionnaire to assess QoL. The Patient Determined Disease Steps (PDDS) was used to measure disability. Data were analyzed using descriptive statistics, the Mann–Whitney test, the Kruskal Wallis test and Spearman’s coefficient correlation. RESULTS: From the 598 MS patients studied, 384 (64.2%) were female. The mean score for males was higher than females in all SF-36 QoL subscales. The mean age was 32.4 years (SD=8.4). The mean duration of illness was 6.5 years. Patients had the lowest scores in role motioning/emotional scale (mean=42.6, SD=43.3). The PDDS was negatively correlated with all SF-36 QoL subscales. Self Report-36 QoL for MS patients differed significantly through demographic characteristics at a level of significance of 0.05. CONCLUSIONS: Multiple Sclerosis patients have a low QoL score and need more comprehensive management by their treating physicians. Further development of the registration will provide access to the entire population of MS patients and help comprehensively analyze the factors that affect the quality of their lives. Riyadh : Armed Forces Hospital 2018-04 /pmc/articles/PMC8015454/ /pubmed/29664456 http://dx.doi.org/10.17712/nsj.2018.2.20170335 Text en Copyright: © Neurosciences https://creativecommons.org/licenses/by-nc-sa/3.0/Neurosciences is an Open Access journal and articles published are distributed under the terms of the Creative Commons Attribution-NonCommercial License (CC BY-NC). Readers may copy, distribute, and display the work for non-commercial purposes with the proper citation of the original work. |
spellingShingle | Original Article Alhazzani, Adel A. Alqahtani, Mohammed S. Alahmari, Mohammed S. Asiri, Muhannad A. Alamri, Noof M. Sarhan, Leen A. Alkhashrami, Shahad S. Asiri, Abdullmgeed A. Quality of life assessment among multiple sclerosis patients in Saudi Arabia |
title | Quality of life assessment among multiple sclerosis patients in Saudi Arabia |
title_full | Quality of life assessment among multiple sclerosis patients in Saudi Arabia |
title_fullStr | Quality of life assessment among multiple sclerosis patients in Saudi Arabia |
title_full_unstemmed | Quality of life assessment among multiple sclerosis patients in Saudi Arabia |
title_short | Quality of life assessment among multiple sclerosis patients in Saudi Arabia |
title_sort | quality of life assessment among multiple sclerosis patients in saudi arabia |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8015454/ https://www.ncbi.nlm.nih.gov/pubmed/29664456 http://dx.doi.org/10.17712/nsj.2018.2.20170335 |
work_keys_str_mv | AT alhazzaniadela qualityoflifeassessmentamongmultiplesclerosispatientsinsaudiarabia AT alqahtanimohammeds qualityoflifeassessmentamongmultiplesclerosispatientsinsaudiarabia AT alahmarimohammeds qualityoflifeassessmentamongmultiplesclerosispatientsinsaudiarabia AT asirimuhannada qualityoflifeassessmentamongmultiplesclerosispatientsinsaudiarabia AT alamrinoofm qualityoflifeassessmentamongmultiplesclerosispatientsinsaudiarabia AT sarhanleena qualityoflifeassessmentamongmultiplesclerosispatientsinsaudiarabia AT alkhashramishahads qualityoflifeassessmentamongmultiplesclerosispatientsinsaudiarabia AT asiriabdullmgeeda qualityoflifeassessmentamongmultiplesclerosispatientsinsaudiarabia |